Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase EARLY_PHASE1 1Phase 2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Glioblastoma 28Gliosarcoma 13Rectal Neoplasms 12Lung Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Squamous Cell Carcinoma of Head and Neck 10Brain Neoplasms 10Sarcoma 9Prostatic Neoplasms 9Breast Neoplasms 9Astrocytoma 9Uterine Cervical Neoplasms 8Melanoma 8Glioma 8Esophageal Neoplasms 8Pancreatic Neoplasms 7Head and Neck Neoplasms 7Neoplasm Metastasis 5Lymphoma, Follicular 5Oropharyngeal Neoplasms 4Lymphoma, Mantle-Cell 4Leukemia, Lymphocytic, Chronic, B-Cell 4Carcinoma, Squamous Cell 4Stomach Neoplasms 3Ovarian Neoplasms 3Multiple Myeloma 3Mouth Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3Lymphoma, B-Cell 3

Interventions

Temozolomide 11Filgrastim 5Magnetic Resonance Spectroscopy 4Cyclophosphamide 4Carmustine 4Thiotepa 3Radiation 3Etoposide 3Carboplatin 3Azacitidine 3Automobiles 3sargramostim 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2ONC206 2O(6)-benzylguanine 2Nivolumab 2Melphalan 2Immunohistochemistry 2Imiquimod 2Imatinib Mesylate 2Granulocyte Colony-Stimulating Factor 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 22,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 21-methyltryptophan 2vitespin 1veliparib 1vatalanib 1trametinib 1thymoglobulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Ependymoma × Radiation × Clear all
NCT04732065 2026-03-17

PNOC023

University of California, San Francisco

Phase 1 Recruiting
208 enrolled
CNS

Ependymoma, Glioblastoma, Central Nervous System Neoplasms

NCT02722512 2025-02-18

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Terminated
10 enrolled
CNS

Astrocytoma, Ependymoma, Glioblastoma

NCT00634231 2023-08-25

A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors

Candel Therapeutics, Inc.

Phase 1 Completed
8 enrolled
CNS

Astrocytoma, Ependymoma, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡